Pedram Gerami Selected Research

Imiquimod (Aldara)

7/2017

Eccrine Syringofibroadenoma in Association With Acquired Epidermodysplasia Verruciformis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedram Gerami Research Topics

Disease

34	Melanoma (Melanoma, Malignant) 04/2024 - 09/2008
32	Neoplasms (Cancer) 01/2024 - 08/2009
11	Nevus (Nevi) 07/2023 - 04/2010
4	Mycosis Fungoides 03/2019 - 02/2008
3	Inflammation (Inflammations) 09/2010 - 04/2006
3	Skin Diseases (Skin Disease) 01/2010 - 01/2006
2	Basal Cell Carcinoma (Rodent Ulcer) 10/2023 - 01/2019
2	Dysplastic Nevus Syndrome (Dysplastic Nevus) 05/2023 - 12/2012
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2013
2	Exanthema (Rash) 11/2010 - 09/2010
2	Lymphoma (Lymphomas) 12/2009 - 08/2008
1	Pigmented Nevus (Melanocytic Nevus) 07/2023
1	Blue Nevus 05/2023
1	Epithelioid and Spindle Cell Nevus (Spitz Nevus) 05/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Anemia 01/2018
1	Infections 07/2017
1	Warts (Wart) 07/2017
1	Lymphatic Metastasis 01/2017
1	Alopecia (Baldness) 12/2016
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2015
1	Hyperplasia 03/2015
1	Fibrosis (Cirrhosis) 05/2014
1	Disease Progression 07/2012
1	Breast Neoplasms (Breast Cancer) 11/2010
1	Calcinosis 01/2010
1	Calcinosis Cutis 01/2010
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 12/2009
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2009

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2011
7	Phosphotransferases (Kinase)IBA 01/2024 - 04/2017
6	Messenger RNA (mRNA)IBA 01/2023 - 08/2014
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2009
5	Cyclin D1IBA 01/2018 - 09/2008
4	AntigensIBA 07/2023 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 03/2023 - 09/2010
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2016 - 01/2006
2	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2023 - 05/2023
2	NAD (NADH)IBA 05/2023 - 12/2020
2	Mitogen-Activated Protein KinasesIBA 12/2020 - 02/2012
2	CytokinesIBA 03/2019 - 03/2015
2	ChromatinIBA 03/2017 - 02/2013
2	ParaffinIBA 01/2017 - 08/2009
2	Indicators and Reagents (Reagents)IBA 07/2012 - 09/2008
1	Hematoxylin (Haematoxylon)IBA 04/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2024
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2024
1	tyrosine receptor (receptor, tyrosine)IBA 01/2024
1	Desmoglein 1IBA 11/2023
1	MART-1 AntigenIBA 11/2023
1	SmokeIBA 10/2023
1	Anaplastic Lymphoma KinaseIBA 07/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	Aurora Kinase AIBA 01/2023
1	1- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimideIBA 12/2022
1	Protein Kinases (Protein Kinase)IBA 08/2022
1	Coloring Agents (Dyes)IBA 08/2022
1	Melanins (Melanin)IBA 12/2020
1	CateninsIBA 12/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	Voriconazole (Vfend)FDA LinkGeneric 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Transaminases (Aminotransferases)IBA 01/2018
1	Imiquimod (Aldara)FDA LinkGeneric 07/2017
1	Cimetidine (Biomet)FDA LinkGeneric 07/2017
1	Long Noncoding RNAIBA 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	Triamcinolone (Aristocort)FDA Link 12/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2016
1	Transcription Factors (Transcription Factor)IBA 03/2015
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 03/2015
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 03/2015
1	CollagenIBA 05/2014
1	VemurafenibIBA 12/2012
1	ErbB Receptors (EGF Receptor)IBA 09/2010
1	Antineoplastic Agents (Antineoplastics)IBA 09/2010
1	Panitumumab (Vectibix)FDA Link 09/2010
1	Lapatinib (GW572016)FDA Link 09/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2010
1	Cetuximab (Erbitux)FDA Link 09/2010
1	Complement System Proteins (Complement)IBA 04/2010
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2010
1	Rituximab (Mabthera)FDA Link 01/2010
1	Methotrexate (Mexate)FDA LinkGeneric 01/2010
1	Alemtuzumab (Campath)FDA Link 12/2009
1	Urokinase Plasminogen Activator ReceptorsIBA 11/2009
1	G(M3) GangliosideIBA 11/2009
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2009
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2009
1	Bexarotene (LGD1069)FDA Link 02/2008

Therapy/Procedure

10	Therapeutics 07/2023 - 01/2006
2	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 09/2018
2	Radiotherapy 01/2019 - 11/2010
1	Ambulatory Care (Outpatient Care) 10/2023
1	Surgical Amputation (Amputations) 05/2023
1	Molecular Targeted Therapy 11/2019
1	Drug Therapy (Chemotherapy) 01/2019
1	Cryosurgery 07/2017
1	Injections 12/2016